Temozolomide for corticotroph pituitary adenomas refractory to standard therapy

Troy H. Dillard, S. Humayun Gultekin, Johnny B. Delashaw, Chris G. Yedinak, Edward A. Neuwelt, Maria Fleseriu

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Temozolomide for corticotroph pituitary adenomas refractory to standard therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences